Objective-Apolipoprotein E (apoE) exerts potent antiinflammatory effects. Here, we investigated the effect of apoE on the functional phenotype of macrophages. Methods and Results-Human apoE receptors very-low-density lipoprotein receptor (VLDL-R) and apoE receptor-2 (apoER2) were stably expressed in RAW264.7 mouse macrophages. In these cells, apoE downregulated markers of the proinflammatory M1 phenotype (inducible nitric oxide synthase, interleukin [IL]-12, macrophage inflammatory protein-1␣) but upregulated markers of the antiinflammatory M2 phenotype (arginase I, SOCS3, IL-1 receptor antagonist [IL-1RA]). In addition, M1 macrophage responses (migration, generation of reactive oxygen species, antibody-dependent cell cytotoxicity, phagocytosis), as well as poly(I:C)-or interferon-␥-induced production of proinflammatory cytokines; cyclooxygenase-2 expression; and activation of nuclear factor-B, IB, and STAT1, were suppressed in VLDL-R-or apoER2-expressing cells. Conversely, the suppression of the M2 phenotype and the enhanced response to poly(I:C) were observed in apoE-producing bone marrow macrophages derived from VLDL-Rdeficient mice but not wild-type or low-density lipoprotein receptor-deficient mice. The modulatory effects of apoE on macrophage polarization were inhibited in apoE receptor-expressing RAW264.7 cells exposed to SB220025, a p38 mitogen-activated protein kinase inhibitor, and PP1, a tyrosine kinase inhibitor. Accordingly, apoE induced tyrosine kinase-dependent activation of p38 mitogen-activated protein kinase in VLDL-R-or apoER2-expressing macrophages. Under in vivo conditions, apoE Ϫ/Ϫ mice transplanted with apoE-producing wild-type bone marrow showed increased plasma IL-1RA levels, and peritoneal macrophages of transplanted animals were shifted to the M2 phenotype (increased IL-1RA production and CD206 expression).
A polipoprotein E (apoE) is a major protein component of very-low-density lipoproteins (VLDL) and high-density lipoproteins. Observations in human carriers of apoE variants and in apoE-deficient mice suggest an important role of this apolipoprotein in preventing atherosclerosis. 1 The antiatherogenic effects of apoE are usually attributed to its ability to regulate VLDL production and to facilitate hepatic clearance of VLDL and chylomicron remnants. 1 However, apoE protects against atherosclerosis even in the absence of measurable effects on plasma lipoprotein metabolism. For instance, transgenic expression of apoE in arterial wall reduces the formation of atherosclerotic lesions without affecting plasma lipoprotein profile. 2, 3 Conversely, enhanced atherosclerosis is observed in apoE ϩ/ϩ animals transplanted with bone marrow (BM) from apoE-deficient mice. 4 These results suggest that apoE exerts local antiatherogenic effects in the arterial wall that are independent from regulation of plasma lipoprotein metabolism.
An increasing body of evidence suggests that atherosclerosis is a chronic inflammatory disease. Macrophages assume a critical role in the initiation and the perpetuation of intravascular inflammation through their ability to produce an array of cytokines and chemokines, to generate reactive oxygen species, and to process and present antigens to CD4 ϩ T cells. Importantly, macrophages represent a heterogeneous cell population that is distinctly activated by various microenvironmental signals. [5] [6] [7] [8] Proatherogenic factors such as Th1 cytokines (eg, interferon-␥ [IFN-␥], interleukin [IL] 1␤ [IL-1␤]) and Toll-like receptor ligands (eg, poly(I:C), lipopolysaccharide) induce a classical activation profile (M1) characterized by enhanced production of proinflammatory cytokines, expression of major histocompatibility complex (MHC) class II molecules, and generation of free radicals including inducible nitric oxide synthase (iNOS)-derived nitric oxide (NO). In contrast, exposure of macrophages to Th2 cytokines (IL-4, IL-13) promotes the alternative activation profile (M2) comprising secretion of antiinflammatory factors (eg, IL-1 receptor antagonist [IL-1RA]), expression of the mannose receptor CD206 or hemoglobin receptor CD163, and reduced NO production due to the upregulation of arginase I activity, which converts arginine to ornithine and urea. In addition, alternatively activated macrophages demonstrate higher phagocytic capacity and reduced motility and cytotoxic effects.
Although the presence of both M1-and M2-polarized macrophages in the arterial wall and the progressive M2 to M1 switch during atherosclerotic lesion development have been recently documented, 9 the mechanisms contributing to the generation of distinct macrophage phenotypes in context of atherosclerosis remain unclear. In the present study, we report that apoE exerts antiinflammatory activity by switching the macrophage phenotype from M1 to M2 in a process involving signaling via the very-low-density lipoprotein receptor (VLDL-R) or the apoE receptor-2 (apoER2).
Methods

BM Transplantation
Homozygous apoE Ϫ/Ϫ and low-density lipoprotein receptor-deficient mice, both on a C57BL/6J background, and wild-type (WT) C57BL/6J mice were obtained from Charles River Laboratories (Sulzfeld, Germany). VLDL-R Ϫ/Ϫ and apoER2 Ϫ/Ϫ mice were generated as described previously. 10, 11 To induce BM aplasia, apoE Ϫ/Ϫ mice (12 animals) were exposed to a single dose of 11 Gy of total body irradiation. BM (10 6 cells) isolated by flushing femurs from apoE Ϫ/Ϫ and WT mice were administered intravenously. Chimerism was assessed in leukocyte DNA by polymerase chain reaction (PCR).
ApoE Receptor Cloning and Stable Transfections
Human endothelial and brain DNA were reverse transcribed and subjected to PCR with human VLDL-R and apoER2 gene-specific primers. PCR products corresponding to VLDL-R and apoER2 were ligated into expression vector pBK-CMV. RAW264.7 cells were stably transfected by electroporation. Positive clones were isolated and identified by Western blot.
Analytic Procedures
Expression of phenotype-specific markers and phosphorylation of protein kinases p38 mitogen-activated protein kinase and Akt were examined by Western blot. Production of cytokines, prostaglandin E 2 (PGE 2 ), and NO were examined with ELISA or enzyme immunoassay. ApoE binding, CD206 and MHC-II cell surface expression, and fluorescent latex bead uptake for estimation of phagocytosis were investigated by flow cytometry. Transcription factor activity was examined by luciferase reporter assays using gene vectors p(B) 5 -Luc and p(GAS) 4 -Luc. NO and H 2 O 2 production were assessed using fluorescence spectroscopy. Production of urea and antibody-dependent cell cytotoxicity were investigated by light spectrometry.
Statistical Analysis
Data are presented as meanϮSD from at least 3 separate experiments or as results representative of at least 3 repetitions, unless indicated otherwise. Comparisons were performed with the 2-tailed Student t test. Detailed Supplemental Methods are available online at http://atvb.ahajournals.org.
Results
Generation of Stable Transfectants Expressing Functional VLDL-R-or apoER2
Two stable cell lines were generated by transfection of RAW264.7 macrophages with plasmids encoding human variants of VLDL-R or apoER2 expressed in the vasculature. Each cell line produced proteins with expected molecular weights cross-reacting with antibodies against either VLDL-R or apoER2, displayed specific binding of apoE, and produced no endogenous apoE (for details, see Supplemental Methods).
ApoE Induces Typical Characteristics of Alternative Activation in VLDL-R-or apoER2-Expressing RAW264.7 Macrophages
To investigate whether apoE drives macrophages toward the M2 phenotype, RAW264.7 cells expressing VLDL-R or apoER2 were incubated for 24 hours with apoE, and the expression of M1 and M2 polarization markers was investigated. Figure 1A demonstrates that, relative to control cells, the expression of iNOS, a hallmark of classically activated macrophages, 5, 6 was downregulated in VLDL-R-or apoER2expressing macrophages in the presence of apoE. By contrast, cells expressing VLDL-R or apoER2 displayed upregulated arginase I, FIZZ1/RELM, and SOCS3, 3 markers of alternative macrophage activation, in response to apoE. 6 -8 Consistent with these observations, apoE decreased the enzymatic activity of iNOS, as inferred from reduced nitrite/nitrate generation, whereas the production of urea, an arginase I product, was increased ( Figure 1B ). The latter effect was concentration-dependent and reached the maximum at 5 g/mL apoE. In addition, preincubation of VLDL-R-or apoER2-expressing macrophages with apoE reduced the steady-state production of M1 cytokines IL-12 and macrophage inflammatory protein-1␣, whereas the production of M2 cytokines IL-1RA and granulocyte colony-stimulating factor was enhanced in a concentration-dependent fashion, indicating that apoE shifts the balance from a proinflammatory toward an antiinflammatory cytokine profile ( Figure 1C ). Endotoxin contamination did not account for the modulatory effects of apoE on macrophage functional phenotype (see Supplemental Materials).
As IL-4 and IL-13, 2 cytokines secreted by macrophages, are typical inducers of the alternative macrophage pheno-type, 6 -8 we next examined whether the activation pattern seen in RAW264.7 cells expressing VLDL-R or apoER2 is a direct effect of apoE or whether it is conferred via intermediate products. As shown in Figure 1D , exposure of macrophages to apoE failed to induce IL-4 production but led to a moderate release of IL-13 into cell media. However, recombinant mouse IL-13 receptor ␣2 (IL-13R␣2), which was previously shown to abrogate cytokine effects under both in vitro and in vivo conditions, 12, 13 failed to influence apoEstimulated IL-1RA and G-CSF production in VLDL-R-or apoER2-expressing cells, which argues against the notion that apoE drives the M2 polarization via the IL-13-mediated paracrine loop.
ApoE Alters Functional Phenotype in VLDL-R-or apoER2-Expressing RAW264.7 Macrophages
As alternative macrophage activation is accompanied by changes of cell function such as decreased cell motility and cytotoxicity and increased phagocytosis, 5-7 we next investigated the propensity of apoE to modulate the macrophage functional phenotype in RAW264.7 cells expressing VLDL-R or apoER2. As shown in Figure 2A , the induction of chemotaxis by 2 common leukocyte chemoattractants, macrophage colony-stimulating factor and N-formylmethionylleucyl-phenylalanine, was equally effective in control and apoE receptor-expressing RAW264.7 macrophages. However, these migratory responses were diminished in the presence of apoE only in cells expressing VLDL-R or apoER2. Similarly, cytotoxic effects of macrophages, as determined by hemoglobin release from opsonized erythrocytes, were attenuated in the presence of apoE in VLDL-R-or apoER2-expressing cells but not in control cells ( Figure 2B ). This was likely a consequence of reduced reactive oxygen species (ROS) generation, as the preincubation of RAW264.7 macrophages with apoE decreased the ROS generation rate in VLDL-R-and apoER2-expressing cells, whereas no inhibitory effects were noted in control cells ( Figure 2C ). In addition, pretreatment with apoE consistently increased the number of VLDL-R-or apoER2-expressing macrophages phagocytosing fluorescein isothiocyanate-latex beads ( Figure  2D ). By contrast, apoE failed to affect phagocytosis in control RAW264.7 macrophages.
ApoE Inhibits the Proinflammatory Response of RAW264.7 Macrophages to IFN-␥ and Poly(I:C)
Alternatively activated macrophages are characterized by impaired response to M1 stimuli, such as Th1 cytokines and Toll-like receptor ligands. 6 -8 Therefore, we next assessed the ability of RAW264.7 macrophages to respond to poly(I:C) or IFN-␥ stimulation with cyto/chemokine production and activation of transcription factors nuclear factor-B (NF-B) or STAT1. ApoE alone failed to induce cytokine or chemokine production. However, following exposure to apoE, VLDL-Ror apoER2-expressing macrophages were significantly suppressed with respect to production of proinflammatory cytokines/chemokines (IL-12, tumor necrosis factor-␣, monocyte chemotactic protein-1, IL-6) as compared with control RAW264.7 cells ( Figure 3A) . Moreover, the expression of cyclooxygenase-2 (COX-2), a marker of proinflamatory macrophage activation, and the release of a COX-2 product, PGE 2 , in response to IFN-␥ and poly(I:C) were both suppressed in the presence of apoE in VLDL-R-or apoER2expressing but not in control macrophages ( Figure 3B ). The reduced proinflammatory response to M1 stimuli was further reflected at the transcriptional level by impaired upregulation of poly(I:C)-induced NF-B activation or IFN-␥-induced STAT1 activation in apoE-pretreated VLDL-R or apoER2expressing macrophages transiently transfected with reporter plasmids containing either NF-B-or STAT1-responsive promoters ( Figure 3C ). At the pretranscriptional level, degradation and phosphorylation of IB, a component of the NF-B complex, as well as phosphorylation of STAT1, which both precede the initiation of transcription by NF-Bor STAT1, respectively, were abolished in VLDL-R or apoER2-expressing macrophages in the presence of apoE ( Figure 3D ). By contrast, both NF-B/STAT1 activation and IB/STAT-1 phosphorylation in response to poly(I:C) or IFN-␥ remained unaffected by apoE in control RAW264.7 macrophages (not shown).
VLDL-R-Deficient BM Macrophages Display Enhanced Proinflammatory Phenotype
We next examined whether the effects of apoE on macrophage phenotype are also observed in normal primary macrophages, which do not overexpress apoE receptors. Initial studies documented the expression of VLDL-R but not apoER2 in BM-derived murine macrophages ( Figure 4A ). In contrast to RAW264.7 cells, BM macrophages produced endogenous apoE and the amounts of apolipoprotein released into media within the 24-hour incubation period were comparable in cells derived from WT, VLDL-R Ϫ/Ϫ , apoER2 Ϫ/Ϫ , and low-density lipoprotein receptor-deficient mice ( Figure  4B ). As shown in Figure 4B , the expression of M2 polariza- Figure 2 . ApoE induces M2 functional phenotype in VLDL-Ror apoER2-expressing RAW264.7 cells. VLDL-R, apoER2, or WT RAW264.7 macrophages were incubated with apoE (5 g/mL) for 24 hours. A, Cell suspension (2.0ϫ10 5 /mL) was exposed to chemoattractants N-formylmethionyl-leucylphenylalaline (0.1 mol/L) or macrophage colony-stimulating factor (0.1 mol/L) for 2 hours. Cells emigrated through the insert membrane were fixed, stained, and quantified as described in Methods. Shown are results from 3 independent experiments. B, Adhering cells were incubated for 2 hours with opsonized erythrocytes, and hemoglobin released to the media was quantified as described in Methods. Shown are results from 3 independent experiments. C, Cell suspensions (5.0ϫ10 5 /mL) were loaded with 2,7-dichlorodihydrofluorescein diacetate and dichlorofluorescein fluorescence reflecting tion markers (arginase 1, SOCS3) was reduced after 24 hours of incubation in cells obtained from VLDL-R Ϫ/Ϫ but not apoER2 Ϫ/Ϫ mice. In addition, VLDL-R-deficient BM macrophages were characterized by reduced production of urea, as well as secretion of M2 cytokines (IL-1RA, IL-13; Figure  4C ). By contrast, the M1 functional phenotype was augmented in VLDL-R Ϫ/Ϫ macrophages as reflected by the increased production of inflammatory cytokines/chemokines (monocyte chemotactic protein-1, IL-6), the COX-2 expression, and the release of PGE 2 in response to stimulation with poly(I:C) ( Figure 4D and 4E ). No differences with regard to M1/M2 polarization were noted between BM macrophages derived from WT and low-density lipoprotein receptordeficient mice ( Figure 4B to 4E).
ApoE Signals via p38 Mitogen-Activated Protein Kinase and Tyrosine Kinase
Binding of apoE to VLDL-R or apoER2 receptors results in the recruitment of intracellular adapter protein disabled-1 (Dab1) and culminates in the activation of protein kinase Akt. 14 However, RAW264.7 cells do not express Dab1 (not shown), and accordingly, apoE failed to produce Akt phosphorylation both in control and apoE receptor-expressing macrophages ( Figure 5A) . By contrast, time-dependent increase in p38 mitogen-activated protein kinase (p38 MAPK ) phosphorylation on incubation with apoE was observed in macrophages expressing VLDL-R or apoER2 but not in control cells ( Figure 5A ). The apoE-induced p38 MAPK phos-phorylation was substantially reduced after preincubation of macrophages with PP1A (10.0 mol/L), a potent inhibitor of the Src family of tyrosine kinases ( Figure 5B ). To assess the involvement of p38 MAPK and tyrosine kinase activation in the modulatory effects of apoE on macrophage M1/M2 phenotype, the apoE-induced production of IL-1RA was examined in macrophages preincubated with PP1A or SB203580, a specific inhibitor of p38 MAPK . As shown in Figure 5C , both inhibitors abolished apoE-induced production of M2 cytokines in VLDL-R-or apoER2-expressing RAW264.7 cells.
ApoE Directs Macrophages Toward the M2 Phenotype In Vivo
To assess the influence of apoE on macrophage polarization under in vivo condition, chimeric mice were created by transplanting BM from C57Bl/6 (WT) or apoE-deficient (apoE Ϫ/Ϫ ) mice into apoE-deficient animals. C57Bl/6 macrophages were previously demonstrated to synthesize and secrete apoE in a paracrine fashion. As shown in Figure 6A (left upper panel), genotyping of genomic DNA isolated from peripheral leukocytes of apoE Ϫ/Ϫ 3apoE Ϫ/Ϫ transplanted animals revealed 1 PCR product characteristic for apoEdeficient mice, whereas an additional WT-specific PCR product was seen in WT3apoE Ϫ/Ϫ transplanted animals. In addition, apoE was detected in supernatants of peritoneal macrophages elicited from WT3apoE Ϫ/Ϫ -but not apoE Ϫ/Ϫ 3apoE Ϫ/Ϫ -transplanted animals ( Figure 6A, left lower panel) . Finally, WT3apoE Ϫ/Ϫ transplanted animals displayed significantly 5 -Luc or p(Gas)-Luc reporter plasmids; stimulated for 24 hours with, respectively, poly(I:C) (10 ng/mL) or IFN-␥ (50 ng/mL) with or without apoE; and analyzed for luciferase. Luminescence level in unstimulated cells was set as 1. ApoE alone did not change luminescence levels. Shown are results from 3 to 4 independent experiments. *PϽ0.05, §PϽ0.01, -apoE vs ϩapoE. D, Cells were exposed to poly(I:C) or IFN-␥ for the indicated times, and lysates were probed with antibodies against the total (t) and phosphorylated (p) isoforms of IB and STAT1. Shown are blots representative of 3 to 5 independent experiments. reduced cholesterol levels and improved plasma lipoprotein profile ( Figure 6A, right panel) . Collectively, these data demonstrate a successful repopulation of BM-ablated apoE Ϫ/Ϫ mice with macrophages producing functional apoE.
No significant differences were observed between apoE Ϫ/Ϫand WT-transplanted animals with regard to plasma levels of proinflammatory cytokines (not shown). However, concentrations of the antiinflammatory IL-1RA were significantly reduced and elevated in animals, which received BM without and with apoE-secreting macrophages, respectively ( Figure  6B ). To characterize the functional macrophage phenotype in transplanted animals, peritoneal macrophages were examined for the expression of M1/M2 polarization markers. As shown in Figure 6C , macrophages obtained from WT3apoE Ϫ/Ϫtransplanted animals were characterized by reduced production of M1 cytokine IL-12, whereas the production of M2 cytokine IL-1RA was increased. In addition, these cells demonstrated reduced surface expression of MHC-II, an M1 polarization marker (WT: 112Ϯ28; apoE Ϫ/Ϫ 78Ϯ24 arbitrary units, nϭ6, PϽ0.05), whereas the expression of CD206, an M2 polarization marker, was increased (WT: 106Ϯ30; apoE Ϫ/Ϫ 147Ϯ34 arbitrary units, nϭ6, PϽ0.05) ( Figure 6D ).
Discussion
Previous studies support a role of apoE as an immunomodulatory agent. Initial observations demonstrated that the infection of apoE knockout mice with Listeria monocytogenes or Klebsiella pneumoniae results in an increased susceptibility to death, as well as elevated serum levels of proinflammatory (M1) cytokines, such as tumor necrosis factor-␣, as compared with WT animals. 15, 16 Moreover, apoE-deficient mice injected with microbial stimuli (ie, poly(I:C), lipopolysaccharide), which drive macrophages into the M1 inflammatory state, presented with exaggerated tumor necrosis factor-␣, IL-6, IL-12, and IFN-␥ production that could be reversed by the administration of exogenous apoE or by the adenoviral . ApoE induces tyrosine kinase-dependent p38 MAPK activation in VLDL-R-or apoER2-expressing RAW264.7 cells. A, VLDL-R, apoER2, or WT RAW264.7 macrophages were incubated with apoE (5 g/mL) for the indicated times. Cell lysates were immunoblotted and probed with antibodies against the total (t) and phosphorylated (p) isoforms of Akt and p38 MAPK . Results are representative of 3 experiments. B, Cells expressing apoE receptors were pretreated for at least 0.5 hours with PP1 (10 mol/L) and exposed to apoE (5 g/mL) for 1 hour. p38 MAPK phosphorylation was analyzed as described above. Shown are results representative of 2 experiments. C, VLDL-R, apoER2, or WT RAW264.7 macrophages were stimulated with apoE (5 g/mL) for 24 hours in the absence or presence of PP1 (10 mol/L) or SB203580 (20 mol/L). Incubation media were analyzed for IL-1RA concentrations. Shown are results from 4 independent experiments. §PϽ0.01, #PϽ0.001, apoE-inhibitor vs apoEϩinhibitor.
reconstitution of apoE expression in the liver. 17, 18 Although these data provide evidence that apoE can suppress the proinflammatory response in vivo, none of the previous studies have assessed the ability of this apolipoprotein to modulate the functional polarization of macrophages. Our present study provides several pieces of evidence documenting that apoE primes macrophages into alternative M2 phenotype with antiinflammatory properties. First, the exposure of apoE receptor-expressing macrophages to apoE led to the expression or the liberation of several markers (ie, arginase I, Fizz1/Relm, SOCS3, IL-1RA) widely recognized as attributes of M2 polarization. Second, the functional characteristics of macrophages exposed to apoE, including reduced migration and attenuated ROS generation and cytotoxicity, as well as upregulated phagocytic activity, were congruent with a typical M2 phenotype. Third, the pretreatment of macrophages with apoE attenuated the proinflammatory activation in response to agents inducing the classical M1 activation profile, such as poly(I:C) and IFN-␥. Fourth, primary macrophages lacking apoE receptor (VLDL-R) displayed less pronounced M2 phenotype and enhanced response to M1 inducing agents. Studies in apoE-deficient mice also documented that peritoneal macrophages producing substantial amounts of apoE display decreased markers of M1 and enhanced markers of M2 phenotype. Taken together, these observations suggest that apoE acting via surface apoE receptors reprograms macrophages toward the M2 phenotype and thereby generates cell population with enhanced antiinflammatory properties.
Monocytes/macrophages assume a critical role in the development of atherosclerosis by infiltrating the arterial wall, where they produce oxidative stress and contribute to perpetuation of proinflammatory processes. 19, 20 Several functional properties of macrophages exposed to apoE are consistent with the notion that these cells exhibit attenuated proinflammatory potential. For instance, reduced motility and propensity to produce ROS would be expected to both reduce the ingress of monocytes into the intima and to locally restrict the oxidative stress and the in situ generation of modified lipoproteins. More importantly, the acquisition of M2 phenotype due to interaction with apoE confers on macrophages the resistance to induction of NF-B and STAT1, 2 transcription factors activated by proinflammatory agents commonly encountered in the atherosclerotic environment. Both activated NF-B and STAT1 have been detected within arterial lesions, where they colocalize with macrophages, and the increased activity of NF-B has been actually observed in aortas from apoE-deficient mice. [21] [22] [23] In this context, it is worth noticing that several antiatherogenic factors known to suppress NF-B or STAT1 activity have been demonstrated to favor M13 M2 phenotypic switching in monocytes and macrophages. For instance, agonists of peroxisome proliferation-activated receptor-␥ (a ligand-activated nuclear receptor with potent antiinflammatory properties), sphingosine 1-phopshate (a lipid constituent of high-density lipoprotein), and FK506 (an immunosuppressive drug) were all shown to induce an antiinflammatory activation profile in mouse and human macrophages. 24 -26 In addition, enhancement of M2 functional phenotype was observed in macrophages cocultured with CD4 ϩ CD25 ϩ regulatory T cells-a lymphocyte subset with potent inflammation-suppressing and antiatherogenic properties. 27 Finally, deficient CD40-TRAF6 signaling was recently shown to drive macrophages toward antiinflammatory M2 signature and to protect against atherosclerosis in apoEdeficient mice. 28 Collectively, these observations suggest that skewing macrophage toward the M2 functional phenotype may represent a universal mechanism used by various protective factors to counteract the development of intravascular inflammation and atherosclerosis.
The molecular mechanism underlying the immunomodulatory effects of apoE on macrophages remains unclear. As apoE absorbs cholesterol from cell membranes, the possibility cannot be excluded that the cholesterol depletion-induced perturbation of membrane microenvironment triggers the signaling cascade required for functional polarization of macrophages. However, apoA-I-another apolipoprotein depleting membranes of cholesterol-failed to affect macrophage phenotype (Baitsch D, Nofer JR, unpublished data, 2008), suggesting that the observed effects were specific for apoE. The results of the present study argue against the role of intermediate macrophage products, such as IL-4 and IL-13, and suggest that the direct effect of apoE mediated via specific receptors, together with the ensuing activation of the intracellular signaling machinery, is required for effective switching of the functional macrophage phenotype. Both VLDL-R and apoER2 were previously demonstrated to bind (via a NPXY tetra-amino acid motif) and to phosphorylate an intracellular adaptor protein Dab1, which in turn mobilizes a common set of signaling modules, including protein tyrosine kinase Fyn, as well as phosphatidylinositol 3-kinase and protein kinase Akt. 14, 29 However, Dab1 is expressed neither in RAW267.4 nor in primary murine macrophages (Bock HH, unpublished data, 2010), and consequently, apoE failed to activate Akt in cells overexpressing VLDL-R or apoER2. Our results suggest rather that activation of p38 MAPK represents a centerpiece of intracellular signaling steering the M13 M2 phenotypic conversion. This possibility is supported by the observation that pharmacological p38 MAPK inhibition fully abolished the production of M2 polarization marker IL-1RA. In this context, it is of note that in human platelets, engagement of apoER2 leads to a potent activation of p38 MAPK in a process dependent on the Src family kinase Fgr and blocked in the presence of Src kinase inhibitor PP1. 30 In our hands, PP1 inhibited both the apoE-induced p38 MAPK activation and the IL-1RA production, suggesting the involvement of a protein tyrosine kinase of as yet unknown identity. Taken together, these data point to common signaling mechanisms used by apoER2 (and possibly also by VLDL-R) to modulate various functional aspects of cells of hematopoietic origin.
The present data do not allow any conclusion with regard to the role played by VLDL-R or apoER2 in the pathogenesis of atherosclerosis. Various isoforms of both receptors were previously found to be expressed in the vasculature, and VLDL-R appears to be particularly abundant in atherosclerotic lesions, where it colocalizes with macrophages and likely facilitates foam cell formation. [31] [32] [33] [34] Actually, transplantation of VLDL-R ϩ macrophages into VLDL-R-deficient mice accelerated the development of atherosclerotic lesions. 35 However, neither generalized nor macrophage-specific VLDL-R deficiency conferred protection against atherosclerosis, and increased intimal thickening after injury has even been observed in VLDL-R-deficient mice. [35] [36] [37] These observations indicate that the proatherogenic effect of VLDL-R arising from the enhanced cholesterol uptake by macrophages may be counterbalanced by some as yet unidentified atheroprotective effects. On the basis of the present results, it is tempting to speculate that the antiinflammatory macrophage polarization triggered by VLDL-R signaling mitigates proatherogenic effects related to VLDL-R-mediated ingestion of cholesterol-rich lipoproteins.
In conclusion, our results demonstrate that apoE signaling via VLDL-R or apoER2 promotes phenotypic switching of macrophages to a novel, antiinflammatory phenotype. These macrophages show decreased activation of transcription factors NF-B and STAT1 and reduced motility and production of free radicals and proinflammatory cytokines. Macrophage conversion from proinflammatory M1 to antiinflammatory M2 phenotype represents a novel antiatherogenic activity of apoE and may be part of a universal mechanism used by various protective agents to counteract the development of atherosclerotic lesions.
